Citation Impact
Citing Papers
Impairment of neutrophil extracellular trap degradation is associated with lupus nephritis
2010 Standout
Effective treatment of severe COVID-19 patients with tocilizumab
2020 Standout
Induction of inflammatory and immune responses by HMGB1–nucleosome complexes: implications for the pathogenesis of SLE
2008
Intracellular Nucleic Acid Sensors and Autoimmunity
2011 StandoutNobel
A phase I/II study of siltuximab (CNTO 328), an anti-interleukin-6 monoclonal antibody, in metastatic renal cell cancer
2010
EULAR recommendations for the management of primary small and medium vessel vasculitis
2008 Standout
Sparse Modeling Reveals miRNA Signatures for Diagnostics of Inflammatory Bowel Disease
2015
The Presence of Anti-Neutrophil Antibodies Reflects Clinical and Genetic Heterogeneity Within Inflammatory Bowel Disease
1998
Topical butyrate improves efficacy of 5‐ASA in refractory distal ulcerative colitis: results of a multicentre trial
2003
Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis
2004 Standout
Review article: the role of butyrate on colonic function
2007 Standout
Antineutrophil cytoplasmic antibodies
2006
Tachykinins and calcitonin gene-related peptide (CGRP) as co-transmitters released from peripheral endings of sensory nerves
1995
High‐mobility group box 1 (HMGB1) protein at the crossroads between innate and adaptive immunity
2007
High mobility group box chromosomal protein 1 plays a role in the pathogenesis of rheumatoid arthritis as a novel cytokine
2003
The pro- and anti-inflammatory properties of the cytokine interleukin-6
2011 Standout
Role of C-Reactive Protein at Sites of Inflammation and Infection
2018 Standout
New Insights into the Biology of Renal Cell Carcinoma
2011 StandoutNobel
A cytokine-mediated link between innate immunity, inflammation, and cancer
2007 Standout
The tachykinin NK1 receptor. Part II: Distribution and pathophysiological roles
1998
A DNA microarray study of nitric oxide-induced genes in mouse hepatocytes: implications for hepatic heme oxygenase-1 expression in ischemia/reperfusion
2002
Cell Biology of Ischemia/Reperfusion Injury
2012 Standout
What causes sarcoidosis?
2002
Local effector functions of capsaicin-sensitive sensory nerve endings: Involvement of tachykinins, calcitonin gene-related peptide and other neuropeptides
1988 Standout
IL-6 as a keystone cytokine in health and disease
2015 Standout
Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism
2016 Standout
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
A Simple Classification of Crohnʼs Disease: Report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998
2000 Standout
Cellular processing of platinum anticancer drugs
2005 Standout
Ageing and infection
2002 Standout
Targeting the IL-6/JAK/STAT3 signalling axis in cancer
2018 Standout
Chemotherapy-Induced Nausea and Vomiting
2008 Standout
Lack of Current Clinical Value of Serological Testing in the Evaluation of Patients with IBD
1999
Placebo analgesia and the heart
2003
High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal
2005 Standout
Antineutrophil cytoplasmic antibodies
1998
Pilot clinical study of Adacolumn cytapheresis in patients with systemic lupus erythematosus
2005
Ulcerative colitis
2020 Standout
Differential Significance of Plasma Visfatin Concentrations according to Adiposity in Children and Adolescents
2013 Standout
The inflammatory response in myocardial injury, repair, and remodelling
2014 Standout
Tendon Injury and Tendinopathy
2005 Standout
IL-6 signal transduction and its physiological roles: the signal orchestration model
2003
Multidimensional degradomics identifies systemic autoantigens and intracellular matrix proteins as novel gelatinase B/MMP-9 substrates
2009
Differential Diagnosis of Glomerular Disease: A Systematic and Inclusive Approach
2013 Standout
Macrophage Cytokines: Involvement in Immunity and Infectious Diseases
2014 Standout
Interleukin-6 and its receptors: A highly regulated and dynamic system
2014
Management of Crohn's Disease in Adults
2009 Standout
Chimeric antigen receptor T-cell therapy — assessment and management of toxicities
2017 Standout
The role of IL-6 and STAT3 in inflammation and cancer
2005 Standout
Neutrophil recruitment and function in health and inflammation
2013 Standout
Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here?
2020 Standout
High-mobility group box 1 represents a potential marker of disease activity and novel therapeutic target in systemic lupus erythematosus
2011
Inflammatory bone loss: pathogenesis and therapeutic intervention
2012 Standout
Immunosenescence of microglia and macrophages: impact on the ageing central nervous system
2016
Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies
2006 Standout
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Immunoblockade of response to capsaicin in the rat vas deferens: evidence for the involvement of endogenous calcitonin gene-related peptide
1987
Tissue-Specific Inducible Expression of Antimicrobial Peptide Genes in Drosophila Surface Epithelia
2000 StandoutNobel
Colonic Bacteria Express an Ulcerative Colitis pANCA-Related Protein Epitope
2000
Current concepts in the diagnosis and management of cytokine release syndrome
2014 Standout
Nitric oxide and the immune response
2001 Standout
Ageing Is Associated with a Prolonged Fever Response in Human Endotoxemia
2001
High-Mobility Group Box-1 in Ischemia-Reperfusion Injury of the Heart
2008
Inflammation as a central mechanism in Alzheimer's disease
2018 Standout
Highly selective agonists for substance P receptor subtypes.
1986
Activation of gene expression in human neutrophils by high mobility group box 1 protein
2003
Addendum to the International Consensus Statement on Testing and Reporting of Antineutrophil Cytoplasmic Antibodies: Quality Control Guidelines, Comments, and Recommendations for Testing in Other Autoimmune Diseases
2003
Minocycline: far beyond an antibiotic
2013 Standout
Soluble IL-6 Receptor Governs IL-6 Activity in Experimental Arthritis: Blockade of Arthritis Severity by Soluble Glycoprotein 130
2003
Adult Chronic Rhinosinusitis: Definitions, Diagnosis, Epidemiology, and Pathophysiology
2003 Standout
Pharmacological receptors for substance P and neurokinins
1987
Inhibition of Activation of the Classical Pathway of Complement by Human Neutrophil Defensins
1998
Multiple tachykinins are produced and secreted upon post-translational processing of the three substance P precursor proteins, α-, β-, and γ-preprotachykinin
1989 StandoutNobel
The Biological Basis for Cardiac Repair After Myocardial Infarction
2016 Standout
A Comprehensive Review of the Placebo Effect: Recent Advances and Current Thought
2007 Standout
Dynamics of gonadotropin-releasing hormone release during a pulse.
1992 Standout
At the Crossroads of Necrosis and Apoptosis: Signaling to Multiple Cellular Targets by HMGB1
2002
High mobility group box chromosomal protein 1 as a nuclear protein, cytokine, and potential therapeutic target in arthritis
2003
Inhibition of Activation of the Classical Pathway of Complement by Human Neutrophil Defensins
1998
Interleukin-6 biology is coordinated by membrane-bound and soluble receptors: role in inflammation and cancer
2006
Chronic Inflammation and Cytokines in the Tumor Microenvironment
2014 Standout
Bacteroides: the Good, the Bad, and the Nitty-Gritty
2007 Standout
DAMPs, PAMPs and alarmins: all we need to know about danger
2006 Standout
Immunogenic Cell Death in Cancer Therapy
2012 Standout
Addendum to the International Consensus Statement on Testing and Reporting of Antineutrophil Cytoplasmic Antibodies
2003
Factors masking HMGB1 in human serum and plasma
2006
Works of F Osakada being referenced
High mobility group (HMG) non-histone chromosomal proteins HMG1 and HMG2 are significant target antigens of perinuclear anti-neutrophil cytoplasmic antibodies in autoimmune hepatitis
1999
Cloning of novel soluble gp130 and detection of its neutralizing autoantibodies in rheumatoid arthritis
2000
Behavioural effects of intrathecally injected tachykinins in rats with peripheral nerve transection
1987
Antigen-specific Th1 cells as direct effectors of Propionibacterium acnes-primed lipopolysaccharide-induced hepatic injury
2001
Prevalence and characterization of novel pANCA, antibodies to the high mobility group non-histone chromosomal proteins HMG1 and HMG2, in systemic rheumatic diseases.
1998
Prevalence and characterization of perinuclear anti-neutrophil cytoplasmic antibodies (P-ANCA) directed against HMG1 and HMG2 in ulcerative colitis (UC)
1998
Anti-neutrophil cytoplasmic antibodies (ANCA) in ulcerative colitis: anti-cathepsin G and a novel antibody correlate with a refractory type
1996
Structure-activity studies of heptapeptide derivatives related to substance P, neurokinin A, B and other tachykinins on smooth muscles
1987
The contractile activities of neurokinin A, B and related peptides on smooth muscles
1986
Novel autoantigens of perinuclear anti-neutrophil cytoplasmic antibodies (P-ANCA) in ulcerative colitis: non-histone chromosomal proteins, HMG1 and HMG2
1997